Firms call for visibility within the EU-SS trading transaction

Formal firms call for tariff visibility imposed under a new US-EU trade agreement, as analysts warn that punitive sectors may risk to blow up the whole deal.

The ambiguity has many conditions for pharmaceutical goods within the trading truce, which is coordinated on Sunday that imposes 15% tariffs on EU goods imported in the US

US President Donald Trump has announced “directly through the” car and everything else “tariff during a news briefing, while at the same time, Pharma is” not related to this transaction. “

Meanwhile, the President of the European Commission Ursul von der Leyen, called “Hour Tariffs for pharmaceuticals.

“We have 15% for pharmaceuticals. No matter what will be accepted, the US president, how to fight pharmaceuticals in general, is on another piece of paper,” said von der Leyen on Sunday.

President Trump said earlier this month that the tariff report on pharmaceutical imports in the US will come “Very soon” u can work up to 200%. It comes after the administration has launched the so -called section 232 Investigation The sector, which studies the impact of the import of pharmacists on national security, with the result, which is due by August.

Even if the pharmaceutical tariffs had to come in the lower range of 15%, analysts believe that the blow to European firms and the wide economy of the block would be significant.

“Questions around pharmaceutical tariffs are very significant, given the volume of imports from the EU,” Wolfe Research analysts wrote on Monday.

Medicines and pharmaceutical products are the largest exports to the US in the US 120 billion dollars in 2024. Analysts have estimated that 15% of the levies could increase the cost of the industry by 13 billion to $ 19 billion a year, In the hall to Reuters.

If the tariff came out above, they say it could blow up a long -term deal.

“Any surprise increases to 15% of the ceiling on pharmaceutical tariffs, threatens a broader trading truce,” Eurosia Group wrote on Monday.

“If there are no disputes about these industry tariffs not a broader agreement,” the European economy’s hit can be serious, Rabobank analysts added.

At the same time, firms remain fighting for the transition to uncertainty.

“We asked for liberation from (tariffs) to the USA, but also in China. That’s what we asked for,” said Philips CEO Roy Jacobs on Tuesday, “Squawk Box Europe”.

“In the current transaction, which was announced that it is not included in it, so we continue to conduct this dialogue.”